GlycoNAVI Proteins

GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.

Source Last Updated
GlycoNAVI Proteins September 04, 2024
Displaying entries 26451 - 26500 of 39437 in total
PDB ID UniProt ID ▲ Title Descriptor
8JDL P49207 Structure of the Human cytoplasmic Ribosome with human tRNA Tyr(GalQ34) and mRNA(UAU) (non-rotated state)
8JDM P49207 Structure of the Human cytoplasmic Ribosome with human tRNA Tyr(GalQ34) and mRNA(UAU) (rotated state)
7QIY P49215 Specific features and methylation sites of a plant ribosome. 40S head ribosomal subunit.
7QIZ P49215 Specific features and methylation sites of a plant 80S ribosome
1E1F P49235 Crystal structure of a Monocot (Maize ZMGlu1) beta-glucosidase in complex with p-Nitrophenyl-beta-D-thioglucoside BETA-GLUCOSIDASE (E.C.3.2.1.21)
1E55 P49235 Crystal structure of the inactive mutant Monocot (Maize ZMGlu1) beta-glucosidase ZMGluE191D in complex with the competitive inhibitor dhurrin
1E56 P49235 Crystal structure of the inactive mutant Monocot (Maize ZMGlu1) beta-glucosidase ZMGluE191D in complex with the natural substrate DIMBOA-beta-D-glucoside
1H49 P49235 CRYSTAL STRUCTURE OF THE INACTIVE DOUBLE MUTANT OF THE MAIZE BETA-GLUCOSIDASE ZMGLU1-E191D-F198V IN COMPLEX WITH DIMBOA-GLUCOSIDE
2DUQ P49256 Crystal structure of VIP36 exoplasmic/lumenal domain, Ca2+/Man-bound form
2DUR P49256 Crystal structure of VIP36 exoplasmic/lumenal domain, Ca2+/Man2-bound form
2E6V P49256 Crystal structure of VIP36 exoplasmic/lumenal domain, Ca2+/Man3GlcNAc-bound form
3WHU P49257 Crystal structure of ERGIC-53/MCFD2, Calcium/Man2-bound form
3WNX P49257 Crystal structure of ERGIC-53/MCFD2, Calcium/Man3-bound form
4GKX P49257 Crystal structure of a carbohydrate-binding domain
4GKY P49257 Crystal structure of a carbohydrate-binding domain
3H4Z P49273 Crystal Structure of an MBP-Der p 7 fusion protein
1SID P49302 MURINE POLYOMAVIRUS COMPLEXED WITH 3'SIALYL LACTOSE POLYOMAVIRUS COAT PROTEIN VP1
1SIE P49302 MURINE POLYOMAVIRUS COMPLEXED WITH A DISIALYLATED OLIGOSACCHARIDE POLYOMAVIRUS COAT PROTEIN VP1
1VPS P49302 POLYOMAVIRUS VP1 PENTAMER COMPLEXED WITH A DISIALYLATED HEXASACCHARIDE
5CPZ P49302 Crystal structure of murine polyomavirus RA strain VP1 in complex with the GT1a glycan
5CQ0 P49302 Crystal structure of murine polyomavirus RA strain VP1 in complex with the GD1a glycan
6UCU P49334 Cryo-EM structure of the mitochondrial TOM complex from yeast (dimer)
1JCQ P49354 CRYSTAL STRUCTURE OF HUMAN PROTEIN FARNESYLTRANSFERASE COMPLEXED WITH FARNESYL DIPHOSPHATE AND THE PEPTIDOMIMETIC INHIBITOR L-739,750
1LD7 P49354 Co-crystal structure of Human Farnesyltransferase with farnesyldiphosphate and inhibitor compound 66
1LD8 P49354 Co-crystal structure of Human Farnesyltransferase with farnesyldiphosphate and inhibitor compound 49
1MZC P49354 Co-Crystal Structure Of Human Farnesyltransferase With Farnesyldiphosphate and Inhibitor Compound 33a
1S63 P49354 Human protein farnesyltransferase complexed with L-778,123 and FPP
1SA4 P49354 human protein farnesyltransferase complexed with FPP and R115777
1TN6 P49354 Protein Farnesyltransferase Complexed with a Rap2a Peptide Substrate and a FPP Analog at 1.8A Resolution
2H6F P49354 Protein Farnesyltransferase Complexed with a Farnesylated DDPTASACVLS Peptide Product at 1.5A Resolution
2H6G P49354 W102T Protein Farnesyltransferase Mutant Complexed with a Geranylgeranylated DDPTASACVLS Peptide Product at 1.85A Resolution
2H6H P49354 Y365F Protein Farnesyltransferase Mutant Complexed with a Farnesylated DDPTASACVLS Peptide Product at 1.8A
2H6I P49354 W102T/Y365F Protein Farnesyltransferase Double Mutant Complexed with a Geranylgeranylated DDPTASACVLS Peptide Product at 3.0A
2IEJ P49354 Human Protein Farnesyltransferase Complexed with Inhibitor Compound STN-48 And FPP Analog at 1.8A Resolution
3E37 P49354 Protein farnesyltransferase complexed with bisubstrate ethylenediamine scaffold inhibitor 5
1JCQ P49356 CRYSTAL STRUCTURE OF HUMAN PROTEIN FARNESYLTRANSFERASE COMPLEXED WITH FARNESYL DIPHOSPHATE AND THE PEPTIDOMIMETIC INHIBITOR L-739,750
1LD7 P49356 Co-crystal structure of Human Farnesyltransferase with farnesyldiphosphate and inhibitor compound 66
1LD8 P49356 Co-crystal structure of Human Farnesyltransferase with farnesyldiphosphate and inhibitor compound 49
1MZC P49356 Co-Crystal Structure Of Human Farnesyltransferase With Farnesyldiphosphate and Inhibitor Compound 33a
1S63 P49356 Human protein farnesyltransferase complexed with L-778,123 and FPP
1SA4 P49356 human protein farnesyltransferase complexed with FPP and R115777
1TN6 P49356 Protein Farnesyltransferase Complexed with a Rap2a Peptide Substrate and a FPP Analog at 1.8A Resolution
2H6F P49356 Protein Farnesyltransferase Complexed with a Farnesylated DDPTASACVLS Peptide Product at 1.5A Resolution
2H6G P49356 W102T Protein Farnesyltransferase Mutant Complexed with a Geranylgeranylated DDPTASACVLS Peptide Product at 1.85A Resolution
2H6H P49356 Y365F Protein Farnesyltransferase Mutant Complexed with a Farnesylated DDPTASACVLS Peptide Product at 1.8A
2H6I P49356 W102T/Y365F Protein Farnesyltransferase Double Mutant Complexed with a Geranylgeranylated DDPTASACVLS Peptide Product at 3.0A
2IEJ P49356 Human Protein Farnesyltransferase Complexed with Inhibitor Compound STN-48 And FPP Analog at 1.8A Resolution
3E37 P49356 Protein farnesyltransferase complexed with bisubstrate ethylenediamine scaffold inhibitor 5
7SRS P49407 5-HT2B receptor bound to LSD in complex with beta-arrestin1 obtained by cryo-electron microscopy (cryoEM)
1GVY P49424 Substrate distorsion by beta-mannanase from Pseudomonas cellulosa

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024